Supernus Pharmaceuticals, Inc. (LON:0LB2)
London · Delayed Price · Currency is GBP · Price in USD 50.75
-0.06 (-0.11%)
Feb 12, 2026, 4:40 PM GMT
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of 2.16 billion as of February 12, 2026. Its market cap has increased by 24.12% in one year.
Market Cap
2.16B
Enterprise Value
1.98B
Revenue
507.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.75
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 79.17M to 2.16B, an increase of 2,625.22%. That is a compound annual growth rate of 27.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.16B | 1.90% |
| Dec 31, 2025 | 2.12B | 32.76% |
| Dec 31, 2024 | 1.59B | 28.49% |
| Dec 29, 2023 | 1.24B | -22.44% |
| Dec 30, 2022 | 1.60B | 39.74% |
| Dec 31, 2021 | 1.15B | 17.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.44B |
| Genus | 2.06B |
| HUTCHMED (China) | 1.88B |